Table 5.
Comparison of inferred prevalence by two models based on the survey answers and the seroprevalence study.
| Autonomous community | Participants, n | Symptom-only model, % (95% CI) | Full model, % (95% CI) | Seroprevalence survey, % (95% CI) |
| Andalucía | 5691 | 2.2 (±0.3) | 4.4 (±0.5) | 2.7 (2.2-3.2) |
| Aragón | 1463 | 2.0 (±0.3) | 3.1 (±0.9) | 4.9 (3.8-6.3) |
| Asturias | 655 | 1.5 (±0.3) | 4.0 (±1.5) | 1.8 (1.3-2.5) |
| Balearic Islands | 1222 | 1.9 (±0.3) | 4.2 (±1.1) | 2.4 (1.6-3.5) |
| Canarias | 1052 | 1.4 (±0.2) | 3.0 (±1.0) | 1.8 (1.1-2.8) |
| Cantabria | 497 | 2.8 (±0.3) | 4.6 (±1.8) | 3.2 (2.1-5.0) |
| Castilla y León | 1994 | 3.7 (±0.4) | 6.1 (±1.0) | 7.2 (6.3-8.1) |
| Castilla-La Mancha | 3469 | 8.0 (±0.3) | 10.4 (±1.0) | 10.8 (9.3-12.4) |
| Catalonia | 5088 | 2.8 (±0.3) | 4.8 (±0.6) | 5.9 (4.9-6.9) |
| Valencia | 102,021 | 1.6 (±0.3) | 3.4 (±0.1) | 2.5 (1.9-3.2) |
| Extremadura | 656 | 2.3 (±0.4) | 4.4 (±1.6) | 3.0 (2.2-4.1) |
| Galicia | 2257 | 1.3 (±0.3) | 2.6 (±0.7) | 2.1 (1.7-2.6) |
| Madrid | 10,365 | 6.1 (±0.4) | 8.8 (±0.5) | 11.3 (9.8-13.0) |
| Murcia | 3566 | 1.5 (±0.3) | 3.2 (±0.6) | 1.4 (0.8-2.4) |
| Navarra | 580 | 3.6 (±0.4) | 5.5 (±1.9) | 5.8 (4.3-7.6) |
| País Vasco | 1007 | 1.9 (±0.4) | 3.9 (±1.2) | 4.0 (3.1-5.2) |
| Rioja, La | 220 | 1.8 (±0.4) | 5.0 (±2.9) | 3.3 (2.4-4.4) |
| National | 141,803 | 3.0 (±0.3) | 5.0 (±1.1) | 5.0 (4.7-5.4) |